Enanta Pharmaceuticals
ENTA
#7540
Rank
ยฃ0.28 B
Marketcap
ยฃ9.67
Share price
2.28%
Change (1 day)
99.49%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -ยฃ57.95 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ65.32 Million. In 2024 the company made an earning of -ยฃ72.19 Million, an increase over its 2023 earnings that were of -ยฃ94.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ57.95 Million-19.73%
2024 -ยฃ72.19 Million-23.87%
2023 -ยฃ94.83 Million4.39%
2022 -ยฃ90.84 Million-4.4%
2021 -ยฃ95.03 Million91.12%
2020 -ยฃ49.72 Million-407.13%
2019 ยฃ16.18 M-78.63%
2018 ยฃ75.76 M117.97%
2017 ยฃ34.75 M-574.65%
2016 -ยฃ7.33 Million-110.83%
2015 ยฃ67.63 M-4.5%
2014 ยฃ70.82 M-638.53%
2013 -ยฃ13.16 Million-137.98%
2012 ยฃ34.62 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.10 B-42,800.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.16 B-21,653.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ1.23 B-2,288.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ3.32 B-5,980.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.18 B-30,534.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ5.97 B-10,688.13%๐Ÿ‡บ๐Ÿ‡ธ USA